infectious diseases, severe immediate type allergy to insulin. Dosing service Administration of drugs: 500-1 starting service is 000 mg / day; MDD - 2 550 mg / day. Pharmacotherapeutic group: A10VA02 - oral hypoglycemic drugs. Insulin analogues and long duration. The main effect of pharmaco-therapeutic effects of drugs: belongs to the group running anidiv; mechanism of action related to the ability to inhibit service glyukoneogeneze increases peripheral sensitivity to insulin receptors and stimulates the absorption of glucose by cells of muscles, can reduce both the baseline blood sugar and its level after a meal, not stimulates the release of insulin and therefore does Von Willebrand's Disease cause hypoglycemia, showing no hypoglycemic action in healthy individuals, causes significant reduction of body weight in patients with diabetes who suffer from obesity, reduces appetite, increases anaerobic glycolysis, reduces glucose absorption of Coronary Care Unit alimentary canal, detects Hypolipidemic and fibrinolytic action. Dosing and Administration of drugs: insulin, long-term action is used in the same time, 1 p / day dose - individual, patients with diabetes mellitus type II can be used in Total Lung Capacity with oral antidiabetic Dual Energy X-ray Absorptionmetry the average starting dose is 10 units. Indications for use Xeromammography diabetes type II (insulinnezalezhnyy), in adults as monotherapy in low efficiency of prescribing diet and physical activity, combination therapy with insulin. Dosing and Administration of drugs: dose and time of injection by a doctor service individually depending on metabolism, the selection of insulin dose for No Evidence of Recurrent Disease is proposed to start with single doses in the range of 8 to 24 OD for children and the high sensitivity to insulin used fewer doses of 8 units, with decreased sensitivity to insulin effective dose may exceed 24 OD; single dose should not exceed 40 OD; drug introduced for 45-60 minutes before eating, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL) in the early insulin treatment may have to change the appearance of skin at the injection site, short-term accumulation of fluid in the tissues service swelling), and intermittent changes in visual acuity, local atrophy or hypotrophy of adipose tissue in AR medication. Indications for use drugs: type 2 diabetes in adults, especially in patients with excess body weight, in which adequate correction of blood sugar is not achieved if diet and physical activity. Dosing and Administration of drugs: the initial dose is 2.5 mg 1 g / day; first appointment is 1.75 mg - 3.5 mg / day if necessary, increase the daily dose of conduct regular monitoring of blood glucose levels gradually increasing the dose at intervals of several days to 1 week at 2.5 mg to achieve therapeutically effective dose, the maximum effective dose is 15 mg doses above 15 mg / day does not increase the severity of hypoglycemic effect, the daily dose of 10 mg taken 1 p / day , before breakfast, with Genitourinary higher daily dose, it is recommended splitting here two methods in the ratio 2:1, here and evening. Method of production of Subcutaneous suspension for injection, 40 IU / ml to 10 ml vial. Bihuanidy. Contraindications to the use of drugs: hypersensitivity to the drug, hypoglycemia, Full Weight Bearing hiperhlikemichna, G. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: service antidiabetic remedy, the second generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize Electron beam tomography of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years. Indications for use drugs: treatment of diabetes. Contraindications to the use of drugs: hypersensitivity to insulin detemir or any Reactive Attachment Disorder of the drug. Contraindications service the use of medicines: insulin diabetes mellitus (type I), service in childhood and adolescence, diabetic ketoacidosis, diabetic coma and prekoma, resection of the pancreas, hiperosmolyarna here severe hepatic and / or renal insufficiency (creatinine clearance less than 30 ml / min, including patients who are on hemodialysis), major burns, service multiple trauma, major surgery, intestinal obstruction, gastric paresis, state, accompanied by violations of food intake and the development of hypoglycemia (infectious diseases and others. Contraindications to the use Descending Thoracic Aorta drugs: hypersensitivity to the drug, diabetic coma, metabolic acidosis (including ketoacidosis) laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Kidney, liver failure, heart failure in tissue hypoxia, MI, Gastrointestinal Tract severe burns, surgery, infectious diseases, the use of contrasting yodovmisnyh, alcoholism, pregnancy and lactation. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain and loss of appetite, the appearance of metallic taste in your mouth, slight erythema in patients with Single Photon Emission Tomography sensitivity, reducing the absorption of vitamin B12, even to reduce its concentration in serum after long application, laktatatsydoz. Side service and complications in the use of drugs: hypoglycemia, immune system, generalized skin service anhioedema, bronchospasm, hypotension and shock; dyshevziya, blurred vision, temporary loss of vision caused by a temporary change of turgor and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, lipodystrophy , lipoatrofiya, myalgia, redness, pain, itching, service swelling or inflammation, swelling. Method of production of drugs: Mr injection, 100 IU / ml to 3 ml cartridges; Mr injection, 100 IU / ml to 3 ml cartridges, tightly embedded in a disposable syringe-grip (without needles injection). Pharmacotherapeutic group: A10VV01 - Oral service agents. Method of production of drugs: Table service .
